/
While bed shortages have happened in pockets throughout the country since the spring, the pressure on hospitals is widespread now reaching into urban and rural communities at an alarming pace.
Keely Connolly thought she would be safe once the ambulance arrived at Hutchinson Regional Medical Center in Kansas.
She was having difficulty breathing because she’d had to miss a kidney dialysis treatment a few days earlier for lack of child care. Her potassium was dangerously high, putting her at risk of a heart attack. But she trusted she would be fine once she was admitted and dialysis was begun.
DENVER, Jan. 11, 2021 /PRNewswire/ SeaStar Medical, a medical technology company delivering novel therapeutic immunomodulating solutions to improve organ function, announced today it has appointed Rick Barnett and Dr.
From Kaiser Health News
Keely Connolly thought she would be safe once the ambulance arrived at Hutchinson Regional Medical Center in Kansas.
She was having difficulty breathing because she’d had to miss a kidney dialysis treatment a few days earlier for lack of child care. Her potassium was dangerously high, putting her at risk of a heart attack. But she trusted she would be fine once she was admitted and dialysis was begun.
She panicked when a nurse told her that no beds were available and that she would have to be transferred possibly more than 450 miles away to Denver. She had heard a rumor about a dialysis patient who died waiting for a bed at a hospital in Wichita, about an hour down the road.
Synlogic Outlines Upcoming Clinical Milestones
- Clinical proof of concept data in 2021 anticipated across multiple programs -
News provided by
Share this article
CAMBRIDGE, Mass., Jan. 11, 2021 /PRNewswire/ Synlogic, Inc. (
Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today outlined significant clinical milestones for 2021 and provided an overview of recent progress. With three programs in clinical trials, multiple proof of concept opportunities, and a preclinical portfolio advancing rapidly towards the clinic, Synlogic is poised for success with a number of data readouts coming in 2021, said Aoife Brennan, M.B. Ch.B., Synlogic s President and Chief Executive Officer. 2020 was a year we will not forget. Despite the external challenges, the Synlogic team moved our programs forward with grit and resilience. We enter 2021 with momentum and the opportunity to truly see the potential of novel Synthetic Biotic m